ArticleOncoTargets and therapy2019

miR-106b promotes proliferation and invasion by targeting Capicua through MAPK signaling in renal carcinoma cancer.

Lu-Jie Miao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.